Clinical Chemistry
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Clinical Chemistry 47: 477-485, 2001;
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (31)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Bonafé, L.
Right arrow Articles by Blau, N.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bonafé, L.
Right arrow Articles by Blau, N.
Related Collections
Right arrow Molecular Diagnostics and Genetics
Right arrow Proteomics and Protein Markers
(Clinical Chemistry. 2001;47:477-485.)
© 2001 American Association for Clinical Chemistry, Inc.


Articles

Diagnosis of Dopa-responsive Dystonia and Other Tetrahydrobiopterin Disorders by the Study of Biopterin Metabolism in Fibroblasts

Luisa Bonafé1, Beat Thöny1, Walter Leimbacher1, Lucja Kierat1 and Nenad Blaua,1

1 Division of Clinical Chemistry and Biochemistry, Department of Pediatrics, University of Zurich, Steinwiesstrasse 75, 8032 Zurich, Switzerland.
a Author for correspondence. Fax 41-1-266-7169; e-mail Nenad.Blau{at}kispi.unizh.ch.

Background: Dopa-responsive dystonia (DRD) and tetrahydrobiopterin (BH4) defects are inherited disorders characterized by monoamine neurotransmitter deficiency with decreased activity of one of the BH4-metabolizing enzymes. The aim of the study was to determine the utility of cultured skin fibroblasts for the diagnosis of these diseases.

Methods: Neopterin and biopterin production and GTP cyclohydrolase I (GTPCH) activity were measured in cytokine-stimulated fibroblasts; 6-pyruvoyltetrahydropterin synthase (PTPS), sepiapterin reductase (SR), and dihydropteridine reductase (DHPR) activities were measured in unstimulated fibroblasts. We examined 8 patients with DRD, 3 with autosomal recessive GTPCH deficiency, 7 with PTPS deficiency, 3 with DHPR deficiency, and 49 controls (35 fibroblast and 14 amniocyte samples).

Results: Fibroblasts from patients with DRD and autosomal recessive GTPCH deficiency showed reduced GTPCH activity (15.4% and 30.7% of normal activity, respectively) compared with controls (P <0.001). Neopterin production was very low and biopterin production was reduced in both disorders. PTPS- and DHPR-deficient cells showed no enzyme activities; in PTPS deficiency the pattern of pterin production was typical (neopterin, 334–734 pmol/mg; controls, 18–98 pmol/mg; biopterin, 0 pmol/mg; controls, 154–303 pmol/mg). Reference values of all enzyme activities and pterin production were measured in fibroblasts and also in amniocytes for prenatal diagnosis.

Conclusions: Cultured skin fibroblasts are a useful tool in the diagnosis of BH4 deficiencies. Intracellular neopterin and biopterin concentrations and GTPCH activity in cytokine-stimulated fibroblasts are particularly helpful in diagnosing patients with DRD.




The following articles in journals at HighWire Press have cited this article:


Home page
J. Neurol. Neurosurg. PsychiatryHome page
M von Mering, H Gabriel, T Opladen, G F Hoffmann, and A Storch
A novel mutation (c.64_65delGGinsAACC [p.G21fsX66]) in the GTP cyclohydrolase 1 gene that causes Segawa disease
J. Neurol. Neurosurg. Psychiatry, February 1, 2008; 79(2): 229 - 229.
[Full Text] [PDF]


Home page
Circ. Res.Home page
J. D. Widder, W. Chen, L. Li, S. Dikalov, B. Thony, K. Hatakeyama, and D. G. Harrison
Regulation of Tetrahydrobiopterin Biosynthesis by Shear Stress
Circ. Res., October 12, 2007; 101(8): 830 - 838.
[Abstract] [Full Text] [PDF]


Home page
J. Nutr.Home page
K. Hyland
Inherited Disorders Affecting Dopamine and Serotonin: Critical Neurotransmitters Derived from Aromatic Amino Acids
J. Nutr., June 1, 2007; 137(6): 1568S - 1572S.
[Abstract] [Full Text] [PDF]


Home page
J. Neurol. Neurosurg. PsychiatryHome page
J L K Van Hove, J Steyaert, G Matthijs, E Legius, P Theys, R Wevers, A Romstad, L B Moller, K Hedrich, D Goriounov, et al.
Expanded motor and psychiatric phenotype in autosomal dominant Segawa syndrome due to GTP cyclohydrolase deficiency
J. Neurol. Neurosurg. Psychiatry, January 1, 2006; 77(1): 18 - 23.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
N. Franscini, E. B. Bachli, N. Blau, M. Fischler, R. B. Walter, A. Schaffner, and G. Schoedon
Functional Tetrahydrobiopterin Synthesis in Human Platelets
Circulation, July 13, 2004; 110(2): 186 - 192.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
N. Blau, L. Bonafe, I. Krageloh-Mann, B. Thony, L. Kierat, M. Hausler, and V. Ramaekers
Cerebrospinal fluid pterins and folates in Aicardi-Goutieres syndrome: A new phenotype
Neurology, September 9, 2003; 61(5): 642 - 647.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
L. Elzaouk, W. Leimbacher, M. Turri, B. Ledermann, K. Burki, N. Blau, and B. Thony
Dwarfism and Low Insulin-like Growth Factor-1 Due to Dopamine Depletion in Pts-/- Mice Rescued by Feeding Neurotransmitter Precursors and H4-biopterin
J. Biol. Chem., July 18, 2003; 278(30): 28303 - 28311.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
N. Nardocci, G. Zorzi, N. Blau, E. Fernandez Alvarez, M. Sesta, L. Angelini, M. Pannacci, F. Invernizzi, and B. Garavaglia
Neonatal dopa-responsive extrapyramidal syndrome in twins with recessive GTPCH deficiency
Neurology, January 28, 2003; 60(2): 335 - 337.
[Abstract] [Full Text] [PDF]


Home page
BrainHome page
A. H. Nemeth
The genetics of primary dystonias and related disorders
Brain, April 1, 2002; 125(4): 695 - 721.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
L. Bonafe, N. Blau, A. P. Burlina, A. Romstad, F. Guttler, and A. B. Burlina
Treatable neurotransmitter deficiency in mild phenylketonuria
Neurology, September 11, 2001; 57(5): 908 - 911.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2001 by the American Association for Clinical Chemistry.